Oncotype DX Breast Cancer Testing
East Sussex Healthcare NHS Trust · awarded 2 March 2026
£273k
Award value
£272,700
1
Supplier
Recorded as a small or medium-sized business
31 Mar 2027
Runs until
from 1 Apr 2026
Who
| Buyer | East Sussex Healthcare NHS Trust Saint Leonards-on-sea |
|---|---|
| Supplier |
Exact Sciences UK, Ltd. |
| Category | services |
| Classification | Pathology services CPV 85111800 |
| Notice published | 3 March 2026 |
What it is for
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is beneficial versus where endocrine therapy alone is sufficient. Additional information: This is a call off contract from framework 2023/S 000-028831 based on previous contracts usage.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
72 awards on file, worth £82.0m.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 31 Mar 2025 | Acute Electronic Patient Record (EPR) Procurement | East Sussex Healthcare NHS Trust | INSIGHT DIRECT (UK) LTD | £20.2m |
| 24 Jun 2025 | Salary Sacrifice Vehicle Scheme | East Sussex Healthcare NHS Trust | Northumbria Healthcare NHS Foundation… | £12.0m |
| 3 Jul 2024 | Sussex CoIN Community of Interest Network | East Sussex Healthcare NHS Trust | BRITISH TELECOMMUNICATIONS PUBLIC… | £7.8m |
| 3 Jul 2024 | Sussex CoIN Community of Interest Network | East Sussex Healthcare NHS Trust | BRITISH TELECOMMUNICATIONS PUBLIC… | £7.8m |
| 27 Mar 2024 | Electronic Document Management System (EDMS) | East Sussex Healthcare NHS Trust | Mizaic Ltd | £3.2m |
Everything East Sussex Healthcare NHS Trust has awarded →
Other contracts won by this supplier
5 awards on file, worth £1.3m.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 26 Feb 2026 | Exact Sciences - Oncotype DX Breast Recurrence Score testsEast of England | Norfolk and Norwich University Hospitals NHS… | Exact Sciences UK, Ltd. | £316k |
| 26 Feb 2026 | Exact Sciences - Oncotype DX Breast Recurrence Score testsEast of England | Norfolk and Norwich University Hospitals NHS… | Exact Sciences UK, Ltd. | £316k |
| 2 Mar 2026 | Oncotype DX Breast Cancer Testing | East Sussex Healthcare NHS Trust | Exact Sciences UK, Ltd. | £273k |
| 19 Mar 2025 | BTH25-027 Oncotype DX Breast Recurrence Score test | Bradford Teaching Hospitals NHS Foundation… | Exact Sciences UK, Ltd. | £194k |
| 20 Oct 2025 | Oncotype DX Breast recurrence score test | Leeds Teaching Hospital NHS Trust | Exact Sciences UK, Ltd. | £192k |